Evidence map›Paper›PMID 41804880›Full record

ArticleJournal of the American Heart Association2026

Specific Deficiency of Naïve CD4+ T Lymphocytes Characterizes Heart Failure and Heightens Mortality Risk in the HRS.

David A Zidar, Michael L Freeman, Brigid M Wilson, Sadeer Al-Kindi, Mina K Chung, Douglas D Gunzler, Sahil A Parikh, Ashish A Sharma, Carey L Shive, Mukesh Jain and 6 more

Abstract read
In one paragraph

Article in Journal of the American Heart Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

David A ZidarHeart Vascular and Thoracic Institute and the Department of Cardiovascular and Metabolic Sciences Cleveland Clinic Foundation Cleveland OH USA.ORCID 0000-0002-2805-3986
Michael L FreemanCase Western Reserve University School of Medicine Cleveland OH USA.ORCID 0000-0002-7690-5258
Brigid M WilsonLouis Stokes Cleveland Veterans Affairs Medical Center Cleveland OH USA.ORCID 0000-0003-2966-2940
Sadeer Al-KindiHouston Methodist DeBakey Heart and Vascular Center Houston TX USA.ORCID 0000-0002-1122-7695
Mina K ChungHeart Vascular and Thoracic Institute and the Department of Cardiovascular and Metabolic Sciences Cleveland Clinic Foundation Cleveland OH USA.ORCID 0000-0002-7835-6045
Douglas D GunzlerCenter for Healthcare Research and Policy Case Western Reserve University at MetroHealth Cleveland OH USA.ORCID 0000-0003-3786-8578
Sahil A ParikhDivision of Cardiology, Center for Interventional Vascular Therapy Columbia University Irving Medical Center New York NY USA.ORCID 0000-0002-0551-5885
Ashish A SharmaDepartment of Pathology and Laboratory Medicine Emory University School of Medicine Atlanta GA USA.ORCID 0000-0001-9444-7046
Carey L ShiveLouis Stokes Cleveland Veterans Affairs Medical Center Cleveland OH USA.ORCID 0000-0002-6908-1246
Mukesh JainDepartment of Molecular Biology, Cell Biology and Biochemistry The Warren Alpert Medical School of Brown University Providence RI USA.ORCID 0000-0002-0975-4760
Jacek SkarbinskiDivision of Research Kaiser Permanente Northern California Oakland CA USA.ORCID 0000-0003-1630-5733
W H Wilson TangHeart Vascular and Thoracic Institute and the Department of Cardiovascular and Metabolic Sciences Cleveland Clinic Foundation Cleveland OH USA.ORCID 0000-0002-8335-735X
Jarrod E DaltonDivision of Infectious Disease and HIV Medicine, Department of Medicine Case Western Reserve University School of Medicine Cleveland OH USA.
Donald D AnthonyCase Western Reserve University School of Medicine Cleveland OH USA.ORCID 0000-0002-1226-5976
Timothy A ChanCenter for Immunotherapy and Immuno-Oncology Cleveland Clinic Foundation Cleveland OH USA.
Bharat ThyagarajanDepartment of Laboratory Medicine and Pathology University of Minnesota Minneapolis MN USA.ORCID 0000-0001-6968-6985

Funding

HRS Yrs29-34: Y33 SSA CoFundingU01AG009740 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Jessica Faul, KENNETH M LANGA · 1990 to 2026
$555.8M
NIA NIH HHS U01 AG009740
6 · The paper itself

Abstract

backgroundHeart failure (HF) is associated with inflammation, but its specific immunophenotypic characteristics and relevant prognostic relationships are poorly established.

methodsIn the HRS (Health and Retirement Study; N=9566), we used multivariable logistic regression, linear regression, and Cox proportional hazard models to describe cross-sectional relationships between HF, plasma biomarkers, leukocyte levels, lymphocyte subsets enumerated by flow cytometry, and all-cause survival. We then analyzed real-world lymphocyte levels, incident HF, and death among outpatients within the US Veterans Affairs Health System (N=38 565).

resultsHF was accompanied by elevated inflammatory cytokine levels as well as relative lymphopenia. This lymphopenia was due to marked reduction in the reservoir of naïve CD4+ T cells, whereas total CD8+ T-cell numbers were not reduced, and the CD4+ effector memory niche was expanded. Importantly, among those without HF, total lymphocytes and naïve CD4+ T cells were each inversely related to aminoterminal pro-B-type natriuretic peptide levels and signaled a higher mortality rate. Linkages between lymphocyte deficiency, HF, and survival were robust to adjustment for low physical activity and a variety of inflammatory biomarkers. In the Veterans Affairs system, real-world lymphopenia (absolute lymphocyte count <1.2: ≈11.5% of outpatient complete blood cell counts) is associated with incident HF (adjusted hazard ratio [aHR], 1.60 [95% CI, 1.38-1.86];

conclusionsHF is associated with total lymphopenia due to a specific deficiency of naïve CD4+ T lymphocytes. Crude lymphopenia among the general ambulatory population can herald incident HF and poor subsequent survival.

Indexed as

CD4-Positive T-LymphocytesHeart FailureLymphopeniaAgedBiomarkersCross-Sectional StudiesCytokinesFemaleHumansIncidenceMaleMiddle AgedPrognosisProportional Hazards ModelsRisk AssessmentRisk FactorsBiomarkersCytokinesheart failureimmune dysfunctioninflammationlymphopenia

Identifiers

PMID41804880
PMCPMC13055730

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.